Literature DB >> 18339843

Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer.

Hirotaka Osada1, Shuta Tomida, Yasushi Yatabe, Yoshio Tatematsu, Toshiyuki Takeuchi, Hideki Murakami, Yutaka Kondo, Yoshitaka Sekido, Takashi Takahashi.   

Abstract

The proneural basic-helix-loop-helix protein achaete-scute homologue 1 (ASH1) is expressed in a very limited spectrum of normal and cancerous cells in a lineage-specific manner, including normal pulmonary neuroendocrine cells and lung cancer cells with neuroendocrine features. Our previous results indicated that ASH1 may play a crucial role in the growth and survival of lung cancers with neuroendocrine features, which prompted us to investigate the molecular function of ASH1 in relation to its involvement in carcinogenic processes. Herein, we report for the first time that ASH1 functions as a dual transcription factor by activating neuroendocrine differentiation markers and also repressing putative tumor suppressors. This protein was found to inactivate DKK1 and DKK3, negative regulators of Wnt/beta-catenin signaling, E-cadherin, and integrin beta1 through ASH1-mediated deacetylation and repressive trimethylation of lysine 27 (H3K27me3) of histone H3 in the promoter regions of DKK1 and E-cadherin. In addition, ASH1-transduced A549 adenocarcinoma cells exhibited markedly altered morphology characteristics compared with lung cancer cells with neuroendocrine features both in vitro and in vivo and also grew faster in vivo. Our results provide important clues for a better understanding of the molecular and cellular biological roles of ASH1 in the process of carcinogenesis of lung cancers with neuroendocrine features and warrant future investigations to shed light on the lineage-specific dependency of this transcription factor with dual functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339843     DOI: 10.1158/0008-5472.CAN-07-5039

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Pathway-BasedFeature Selection Algorithm for Cancer Microarray Data.

Authors:  Nirmalya Bandyopadhyay; Tamer Kahveci; Steve Goodison; Y Sun; Sanjay Ranka
Journal:  Adv Bioinformatics       Date:  2010-03-03

2.  Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma.

Authors:  Luisella Righi; Ida Rapa; Arianna Votta; Mauro Papotti; Anna Sapino
Journal:  Virchows Arch       Date:  2012-03-16       Impact factor: 4.064

3.  Notch signaling triggers the tumor heterogeneity of small cell lung cancer.

Authors:  Lydia Meder; Reinhard Büttner; Margarete Odenthal
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

4.  Ascl1a/Dkk/beta-catenin signaling pathway is necessary and glycogen synthase kinase-3beta inhibition is sufficient for zebrafish retina regeneration.

Authors:  Rajesh Ramachandran; Xiao-Feng Zhao; Daniel Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

5.  Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Authors:  Antonio García Escudero; Enrique Rodríguez Zarco; Juan Carlos Girón Arjona; María José Ríos Moreno; Katherine Gallardo Rodríguez; Ana Vallejo Benítez; Ricardo González Cámpora
Journal:  Virchows Arch       Date:  2016-06-14       Impact factor: 4.064

6.  Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.

Authors:  Tianyun Jiang; Brendan J Collins; Ning Jin; David N Watkins; Malcolm V Brock; William Matsui; Barry D Nelkin; Douglas W Ball
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

7.  Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy.

Authors:  Yuling Xiao; Renata Jaskula-Sztul; Alireza Javadi; Wenjin Xu; Jacob Eide; Ajitha Dammalapati; Muthusamy Kunnimalaiyaan; Herbert Chen; Shaoqin Gong
Journal:  Nanoscale       Date:  2012-11-21       Impact factor: 7.790

8.  ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.

Authors:  Mark D Borromeo; Trisha K Savage; Rahul K Kollipara; Min He; Alexander Augustyn; Jihan K Osborne; Luc Girard; John D Minna; Adi F Gazdar; Melanie H Cobb; Jane E Johnson
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

Review 9.  Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology.

Authors:  Hitoshi Kitamura; Takuya Yazawa; Hanako Sato; Koji Okudela; Hiroaki Shimoyamada
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

10.  Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours.

Authors:  Térèse A Johansson; Gunnar Westin; Britt Skogseid
Journal:  BMC Cancer       Date:  2009-09-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.